已收盘 02-06 16:00:00 美东时间
+0.023
+2.70%
Agreements formalize research partnership combining InterCure's global pharmaceutical platform with Cannasoul's world-class analytics and scientific innovationCollaboration comes amidst reports that the Trump
2025-11-03 21:43
Intercure (NASDAQ:INCR) reported quarterly earnings of $0.01 per share. This is a 700 percent increase over earnings of $0.00 per share from the same period last year. The company reported quarterly sales of $36.292
2025-10-09 16:32
The latest update is out from Intercure ( ($IL:INCR) ). InterCure Ltd. announce...
2025-09-19 21:17
Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologiesTransaction comes as
2025-09-19 20:51
InterCure acquires ISHI, a leading cannabis company, gaining access to premium U.S. brands, advanced cultivation technologies, and exclusive partnerships. The acquisition aligns with InterCure's expansion strategy, leveraging potential U.S. regulatory shifts under the Trump administration, which is exploring cannabis rescheduling from Schedule I to Schedule III. This move strengthens InterCure's position to capitalize on the evolving U.S. cannabi...
2025-09-19 12:48
Intercure ( ($IL:INCR) ) has shared an announcement. InterCure Ltd. announced s...
2025-02-13 14:57
NEW YORK and HERZLIYA, Israel, Feb. 12, 2025 /PRNewswire/ -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will...
2025-02-13 07:35
Intercure ( ($IL:INCR) ) has shared an announcement. Intercure has released a d...
2025-02-11 14:00
Intercure (IL:INCR) has released an update. InterCure Ltd. has secured signific...
2024-12-20 22:07
InterCure press release (NASDAQ:INCR): 1H Revenue of 126M New Israeli Shekels (NIS) Adjusted EBITDA for the six months ending June 30, 2024 was NIS 21M. The company's operating profit was NIS 11M. T...
2024-08-30 21:09